Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

oxindanac

Known as: 5-benzoyl-2,3-dihydro-6-hydroxy-1H-indene-1-carboxylic acid, oxindazac 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryOxindanac, a moderately active cyclooxygenase inhibitor in vitro, is a new antinflammatory agent under clinical… 
  • figure I
1994
1994
The nonsteroidal antiinflammatory drug oxindanac exists as two enantiomers, with most of its pharmacological activity residing in… 
1994
1994
  • J. N. King
  • Journal of veterinary pharmacology and…
  • 1994
  • Corpus ID: 9556024
The pharmacokinetics and pharmacodynamics of the non-steroidal antiinflammatory drug, oxindanac, were assessed simultaneously in… 
1994
1994
A high-performance liquid chromatographic method for the determination of the non-steroidal anti-inflammatory drug, oxindanac, in… 
1993
1993
A simple and humane model of inflammation, induced by the intradermal injection of 0.3 mL of sterile 2% carrageenan, was… 
1993
1993
  • J. N. King
  • Canadian journal of veterinary research = Revue…
  • 1993
  • Corpus ID: 41829607
A simple and humane model of inflammation, induced by the intradermal injection of 0.3 mL of sterile 2% carrageenan, was… 
1989
1989
Gastrointestinal side effects caused by naproxen and oxindanac (a developmental non-steroidal anti-inflammatory drug) were… 
1989
1989
In a double-blind crossover study, the clinical anti-oedematous efficacy was compared of a weak cyclooxygenase inhibitor… 
1989
1989
Prekallikrein and kallikrein are effective as mediators of inflammation on one hand side, on the other hand side they are…